Semler Scientific Class Action Lawsuit Filed Over Alleged False Claims Act Violations

A class action lawsuit has been filed against Semler Scientific, Inc. (NASDAQ: SMLR) for allegedly failing to disclose investigations into violations of the False Claims Act. The lawsuit claims that defendants failed to disclose a material investigation by the US Department of Justice while discussing possible violations in hypothetical terms. The company revealed the investigation in February 2025 and later settled with the DOJ for $29.75 million. The price of Semler Scientific stock fell by 9.88% after the settlement announcement. Investors who purchased or acquired SMLR securities between March 10, 2021, and April 15, 2025, may be eligible to participate in the class action.

A class action lawsuit has been filed against Semler Scientific, Inc. (NASDAQ: SMLR) for allegedly failing to disclose investigations into violations of the False Claims Act. The lawsuit, filed by Rosen Law Firm, claims that Semler Scientific did not disclose a material investigation by the United States Department of Justice (DOJ) into violations of the False Claims Act, while discussing possible violations in hypothetical terms [1]. The company revealed the investigation in February 2025 and later settled with the DOJ for $29.75 million, excluding attorney fees [2]. The price of Semler Scientific stock fell by 9.88% after the settlement announcement.

The class action lawsuit seeks to recover damages for investors who purchased or acquired SMLR securities between March 10, 2021, and April 15, 2025. According to the lawsuit, Semler Scientific made false and/or misleading statements and/or failed to disclose the DOJ investigation, which caused investors to suffer damages [1]. The lawsuit alleges that Semler Scientific's public statements were materially false and/or misleading at all relevant times.

Investors who wish to join the class action can visit the Rosen Law Firm's website or contact Phillip Kim, Esq. at 866-767-3653 or via email at case@rosenlegal.com [1]. The deadline to serve as a lead plaintiff is October 28, 2025.

The lawsuit comes as Semler Scientific, a company that develops and markets technology products and services for evaluating and treating chronic diseases, faces scrutiny over its disclosures and potential violations of the False Claims Act. The settlement with the DOJ and the subsequent stock price decline highlight the potential impact of such investigations on investor confidence and stock performance.

References:
[1] https://www.morningstar.com/news/business-wire/20250829361356/equity-alert-rosen-law-firm-files-securities-class-action-lawsuit-on-behalf-of-semler-scientific-inc-investors-smlr
[2] https://www.prnewswire.com/news-releases/investor-alert-robbins-llp-informs-investors-that-a-class-action-lawsuit-has-been-filed-against-semler-scientific-inc-302542298.html